Intellicheck(US:IDN)2026-03-19 20:17Financial Performance - Revenues for the year ended December 31, 2025 increased by $2,669 or 13% to $22,666 compared to $19,997 for the year ended December 31, 2024, primarily driven by higher SaaS revenue [146]. - Gross profit increased by $2,334 or 13% to $20,500 for the year ended December 31, 2025, with a gross profit margin of 90.4% [147]. - Net income for the year ended December 31, 2025 was $1,273, or $0.07 per share, compared to a net loss of $(918), or $(0.05) per share, for the year ended December 31, 2024 [151]. - Adjusted Gross Profit for the year ended December 31, 2025 was $20,999, representing 92.6% of revenues [159]. - Adjusted EBITDA for 2025 was $2,566 million, compared to $520 million in 2024, indicating a substantial increase in operational performance [163]. - For the year ended December 31, 2025, the company reported a net income of $1,273 million, a significant improvement from a net loss of $918 million in 2024 [163]. Operating Expenses - Operating expenses increased by $80 or 0.4% to $19,414 for the year ended December 31, 2025, with research and development expenses rising by $1,457 or 38% [148]. - The company has approximately $682 million in research and development credits available [164]. Cash Flow and Liquidity - Cash provided by operating activities was $4,541 for the year ended December 31, 2025, compared to cash used in operating activities of $(2,694) for the year ended December 31, 2024 [153]. - As of December 31, 2025, the company had cash and cash equivalents of $9,650 and working capital of $10,123 [152]. - The company anticipates that available cash and expected cash from operations will be sufficient to meet anticipated working capital and capital expenditure requirements for at least the next 12 months [154]. - As of December 31, 2025, the company held cash and cash equivalents of $9,650 million, with no material impact expected from a hypothetical 100 basis point change in interest rates [172]. Tax and Valuation - The company maintained a full valuation allowance of approximately $6,677 against its net deferred tax assets as of December 31, 2025 [143]. - The company has approximately $30,520 million in net operating loss carryforwards, with $10,892 million expiring between 2035 and 2037 [164]. Regulatory and Accounting Changes - The company adopted ASU 2023-09 effective January 1, 2025, which did not have a material impact on its consolidated financial statements [165]. - The company is evaluating the impact of ASU 2024-03, effective after December 15, 2026, which requires disaggregated disclosures for certain expenses [167]. - The company plans to adopt ASU 2025-05 in Q1 2026, which addresses credit loss measurement for accounts receivable and is not expected to materially impact financial statements [168]. Strategic Initiatives - The company filed an S-3 registration in August 2025 to allow for potential future fundraising to support business expansion and other strategic initiatives [155]. - The company expects to continue focusing on capital preservation and liquidity needs in its investment activities [172]. Financing Arrangements - The company has never engaged in off-balance sheet financing arrangements or established special purpose entities [171].